Toll Free: 1-888-928-9744

Global Depression Drugs Market 2017 Industry Research Report

Published: Jul, 2017 | Pages: 123 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

In the last several years, Global market of Depression Drugs developed rapidly, with an average growth rate of 2.88%. In 2016, Global Revenue of Depression Drugs is nearly 15 B USD.

This report studies Depression Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering

•	Intellipharmaceutics
•	Pfizer
•	Eli Lilly
•	Astrazeneca
•	Lundbeck 
•	Allergan
•	GSK
•	Otsuka Pharmaceutical
•	Takeda
•	NHU Group
•	Shionogi
•	APOTEX
•	Kanghong Pharma
•	HUAHAI

Market Segment by Regions, this report splits Global into several key Regions, with revenue, market share and growth rate of Depression Drugs in these regions, from 2012 to 2022 (forecast), like

•	North America
•	Europe
•	Asia-Pacific
•	South America
•	Middle East and Africa

Split by Product Types, with production, revenue, price, market share and growth rate of each type, can be divided into

•	SSRIs
•	SNRIs 
•	Others

Split by applications, this report focuses on consumption, market share and growth rate of Depression Drugs in each application, can be divided into

•	Hospitals
•	Clinics
•	Others
 Table of Contents

1 Depression Drugs Market Overview	1
1.1 Product Overview and Scope of Depression Drugs	1
1.2 Depression Drugs Segment by Types	2
1.2.1 Global Production Market Share of Depression Drugs by Types in 2016	2
1.2.2 SSRIs	3
1.2.3 SNRIs	4
1.3 Depression Drugs Segment by Applications	5
1.3.1 Depression Drugs Consumption Market Share by Applications in 2016	5
1.3.2 Hospitals	6
1.3.3 Clinics	7
1.4 Global Depression Drugs Market by Regions (2012-2022)	8
1.4.1 Global Depression Drugs Market Comparison by Regions	8
1.4.2 North America Depression Drugs Status and Prospect (2012-2022)	9
1.4.3 Asia-Pacific Depression Drugs Status and Prospect (2012-2022)	10
1.4.4 Europe Depression Drugs Status and Prospect (2012-2022)	11
1.4.5 South America Depression Drugs Status and Prospect (2012-2022)	12
1.4.6 Middle East and Africa Depression Drugs Status and Prospect (2012-2022)	13
1.5 Global Depression Drugs Market Size (2012-2022)	14

2 Global Depression Drugs Market Competition by Manufacturers/Brand	15
2.1 Global Depression Drugs Revenue (M USD) and Share by Manufacturers (2015 and 2016)	15
2.2 Global Depression Drugs Gross Margin by Manufacturers (2015 and 2016)	18
2.3 Manufacturers Depression Drugs Headquarters and Established Date	20
2.4 Depression Drugs Market Competitive Situation and Trends	22
2.4.1 Depression Drugs Market Share (%) of Top 3 and Top 5 Manufacturers	22
2.4.2 Mergers & Acquisitions, Expansion	23

3 Global Depression Drugs Sales Revenue (M USD) by Regions (2012-2017)	27
3.1 Global Depression Drugs Revenue (M USD) and Market Share (%) by Regions (2012-2017)	27
3.2 Global Depression Drugs Revenue (M USD) and Gross Margin (%) (2012-2017)	29
3.3 North America Depression Drugs Revenue (M USD) and Gross Margin (%) (2012-2017)	30
3.4 Europe Depression Drugs Revenue (M USD) and Gross Margin (%) (2012-2017)	30
3.5 Asia-Pacific Depression Drugs Revenue (M USD) and Gross Margin (%) (2012-2017)	30
3.6 South America Depression Drugs Revenue (M USD) and Gross Margin (2012-2017)	31
3.7 Middle East and Africa Depression Drugs Revenue (M USD) and Gross Margin (%) (2012-2017)	31

4 Global Depression Drugs Sales Revenue by Types	32
4.1 Global Depression Drugs Revenue and Market Share (%) by Types (2012-2017)	32
4.2 Global Depression Drugs Sales Growth by Type (2012-2017)	34

5 Global Depression Drugs Market Analysis by Applications	35
5.1 Global Depression Drugs Revenue and Market Share (%) by Applications (2012-2017)	35
5.2 Global Depression Drugs Sales Growth Rate (%) by Applications (2012-2017)	37

6 Analysis of Depression Drugs Industry Key Manufacturers	38
6.1 Intellipharmaceutics	38
6.1.1 Company Profile	38
6.1.2 Product Information	39
6.1.3 Revenue, Cost, Gross, and Gross Margin	39
6.2 Pfizer	40
6.2.1 Company Profile	40
6.2.2 Product Information	41
6.2.3 Revenue, Cost, Gross, and Gross Margin	41
6.3 Eli Lilly	41
6.3.1 Company Profile	41
6.3.2 Product Information	42
6.3.3 Revenue, Cost, Gross, and Gross Margin	42
6.4 Astrazeneca	43
6.4.1 Company Profile	43
6.4.2 Product Information	44
6.4.3 Revenue, Cost, Gross, and Gross Margin	44
6.5 Lundbeck	44
6.5.1 Company Profile	44
6.5.2 Product Information	45
6.5.3 Revenue, Cost, Gross, and Gross Margin	46
6.6 Allergan	46
6.6.1 Company Profile	46
6.6.2 Product Information	47
6.6.3 Revenue, Cost, Gross, and Gross Margin	47
6.7 GSK	48
6.7.1 Company Profile	48
6.7.2 Product Information	49
6.7.3 Revenue, Cost, Gross, and Gross Margin	49
6.8 Otsuka Pharmaceutical	49
6.8.1 Company Profile	49
6.8.2 Product Information	50
6.8.3 Revenue, Cost, Gross, and Gross Margin	50
6.9 Takeda	51
6.9.1 Company Profile	51
6.9.2 Product Information	52
6.9.3 Revenue, Cost, Gross, and Gross Margin	52
6.10 NHU Group	53
6.10.1 Company Profile	53
6.10.2 Product Information	54
6.10.3 Revenue, Cost, Gross, and Gross Margin	54
6.11 Shionogi	55
6.11.1 Company Profile	55
6.11.2 Product Information	56
6.11.3 Revenue, Cost, Gross, and Gross Margin	56
6.12 APOTEX	57
6.12.1 Company Profile	57
6.12.2 Product Information	58
6.12.3 Revenue, Cost, Gross, and Gross Margin	58
6.13 Kanghong Pharma	59
6.13.1 Company Profile	59
6.13.2 Product Information	60
6.13.3 Revenue, Cost, Gross, and Gross Margin	61
6.14 HUAHAI	61
6.14.1 Company Profile	61
6.14.2 Product Information	63
6.14.3 Revenue, Cost, Gross, and Gross Margin	63

7 Depression Drugs Manufacturing Cost Analysis	64
7.1 Depression Drugs Key Raw Materials Analysis	64
7.1.1 Key Raw Materials	64
7.1.2 Key Suppliers of Raw Materials	65
7.2 Proportion of Manufacturing Cost Structure	67
7.2.1 Raw Materials	67
7.2.2 Labor Cost	67
7.2.3 Other Costs Analysis	74
7.3 Manufacturing Process Analysis of Depression Drugs	79

8 Industrial Chain, Sourcing Strategy and Downstream Buyers	80
8.1 Depression Drugs Industrial Chain Analysis	80
8.2 Upstream Raw Materials Sourcing	80
8.3 Downstream Buyers	81

9 Marketing Strategy Analysis, Distributors/Traders	84
9.1 Marketing Channel	84
9.1.1 Direct Marketing	84
9.1.2 Indirect Marketing	84
9.1.3 Marketing Channel Development Trend	84
9.2 Market Positioning	85
9.2.1 Pricing Strategy	85
9.2.2 Brand Strategy	86
9.2.3 Target Client	87
9.3 Distributors/Traders List	88

10 Market Effect Factors Analysis	90
10.1 Technology Progress/Risk	90
10.1.1 Substitutes Threat	90
10.1.2 Technology Progress in Related Industry	90
10.2 Consumer Needs/Customer Preference Change	92
10.3 Economic/Political Environmental Change	92

11 Global Depression Drugs Market Forecast (2017-2022)	98
11.1 Global Depression Drugs Revenue (M USD) Forecast (2017-2022)	98
11.2 Global Depression Drugs Revenue (M USD) Forecast by Regions (2017-2022)	98
11.2.1 North America Depression Drugs Revenue (M USD) Forecast (2017-2022)	101
11.2.2 Europe Depression Drugs Revenue (M USD) Forecast (2017-2022)	102
11.2.3 Asia-Pacific Depression Drugs Revenue (M USD) Forecast (2017-2022)	103
11.2.4 South America Depression Drugs Revenue (M USD) Forecast (2017-2022)	104
11.2.5 Middle East and Africa Depression Drugs Revenue (M USD) Forecast (2017-2022)	105
11.3 Global Depression Drugs Revenue by Type (2017-2022)	105
11.4 Global Depression Drugs Revenue Forecast by Application (2017-2022)	106

12 Research Findings and Conclusion	108

13 Appendix	109
Author List	109
Disclosure Section	110
Research Methodology	110
Data Source	111
China Disclaimer	111
List of Tables and Figures

Figure Picture of Depression Drugs	1
Table Classification of Depression Drugs	2
Figure Global Production Market Share of Depression Drugs by Types in 2016	3
Figure Product Picture of SSRIs	3
Figure Product Picture of SNRIs	4
Table Applications of Depression Drugs	5
Figure Depression Drugs Consumption Market Share by Applications in 2016	6
Figure Hospitals	6
Figure Clinics	7
Figure Global Depression Drugs Market Share by Regions 2016	8
Figure North America Depression Drugs Revenue (M USD) and Growth Rate (%) (2012-2022)	9
Figure Asia-Pacific Depression Drugs Revenue (M USD) and Growth Rate (%) (2012-2022)	10
Figure Europe Depression Drugs Revenue (M USD) and Growth Rate (%) (2012-2022)	11
Figure South America Depression Drugs Revenue (M USD) and Growth Rate (%) (2012-2022)	12
Figure Middle East and Africa Depression Drugs Revenue (M USD) and Growth Rate (%) (2012-2022)	13
Figure Global Depression Drugs Revenue (M USD) Status and Outlook (2012-2022)	14
Table Global Depression Drugs Revenue (M USD) by Manufacturers (2015 and 2016)	15
Table Global Depression Drugs Revenue Share (%) by Manufacturers (2015 and 2016)	15
Figure 2015 Global Depression Drugs Revenue Share (%) by Manufacturers	17
Figure 2016 Global Depression Drugs Revenue Share (%) by Manufacturers	18
Table Global Market Depression Drugs Gross Margin of Key Manufacturers (2015 and 2016)	18
Figure Global Market Depression Drugs Gross Margin of Key Manufacturers in 2016	20
Table Manufacturers Depression Drugs Headquarters and Established Date	20
Table Manufacturers Depression Drugs Brand and Sales Area	21
Figure Depression Drugs Market Share (%) of Top 3 Manufacturers 2016	22
Figure Depression Drugs Market Share (%) of Top 5 Manufacturers 2016	23
Table Mergers & Acquisitions, Expansion	23
Table Global Depression Drugs Revenue (M USD) by Regions (2012-2017)	27
Table Global Depression Drugs Revenue Market Share (%) by Regions (2012-2017)	27
Figure Global Depression Drugs Revenue Market Share (%) by Regions (2012-2017)	28
Figure 2012 Global Depression Drugs Revenue Market Share (%) by Regions	28
Figure 2016 Global Depression Drugs Revenue Market Share (%) by Regions	29
Table Global Depression Drugs Revenue (M USD) and Gross Margin (%) (2012-2017)	29
Table North America Depression Drugs Revenue (M USD) and Gross Margin (%) (2012-2017)	30
Table Europe Depression Drugs Revenue (M USD) and Gross Margin (%) (2012-2017)	30
Table Asia-Pacific Depression Drugs Revenue (M USD) and Gross Margin (%) (2012-2017)	30
Table South America Depression Drugs Revenue (M USD) and Gross Margin (%) (2012-2017)	31
Table Middle East and Africa Depression Drugs Revenue (M USD) and Gross Margin (%) (2012-2017)	31
Table Global Depression Drugs Revenue (M USD) by Types (2012-2017)	32
Table Global Depression Drugs Revenue Share (%) by Types (2012-2017)	32
Figure Revenue Share (%) of Depression Drugs by Types (2012-2017)	33
Figure 2016 Revenue Market Share (%) of Depression Drugs by Types	33
Figure Global Depression Drugs Sales Growth (%) by Type (2012-2017)	34
Table Global Depression Drugs Revenue by Applications (2012-2017)	35
Table Global Depression Drugs Revenue Market Share (%) by Applications (2012-2017)	35
Figure Global Depression Drugs Revenue Market Share (%) by Applications (2012-2017)	36
Figure Global Depression Drugs Revenue Market Share (%) by Applications in 2016	36
Table Global Depression Drugs Sales Growth Rate (%) by Applications (2012-2017)	37
Figure Global Depression Drugs Sales Growth Rate (%) by Applications (2012-2017)	37
Table Intellipharmaceutics Company Profile	38
Figure Depression Drugs Product Picture of Intellipharmaceutics	39
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Intellipharmaceutics 2015-2016	39
Table Pfizer Company Profile	40
Figure Depression Drugs Product Picture of Pfizer	41
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Pfizer 2015-2016	41
Table Eli Lilly Company Profile	41
Figure Depression Drugs Product Picture of Eli Lilly	42
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Eli Lilly 2015-2016	42
Table Astrazeneca Company Profile	43
Figure Depression Drugs Product Picture of Astrazeneca	44
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Astrazeneca 2015-2016	44
Table Lundbeck Company Profile	44
Figure Depression Drugs Product Picture of Lundbeck	45
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Lundbeck 2015-2016	46
Table Allergan Company Profile	46
Figure Depression Drugs Product Picture of Allergan	47
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Allergan 2015-2016	47
Table GSK Company Profile	48
Figure Depression Drugs Product Picture of GSK	49
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of GSK 2015-2016	49
Table Otsuka Pharmaceutical Company Profile	49
Figure Depression Drugs Product Picture of Otsuka Pharmaceutical	50
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Otsuka Pharmaceutical 2015-2016	50
Table Takeda Company Profile	51
Figure Depression Drugs Product Picture of Takeda	52
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Takeda 2015-2016	52
Table NHU Group Company Profile	53
Figure Depression Drugs Product Picture of NHU Group	54
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of NHU Group 2015-2016	54
Table Shionogi Company Profile	55
Figure Depression Drugs Product Picture of Shionogi	56
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Shionogi 2015-2016	56
Table APOTEX Company Profile	57
Figure Depression Drugs Product Picture of APOTEX	58
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of APOTEX 2015-2016	58
Table Kanghong Pharma Company Profile	59
Figure Depression Drugs Product Picture of Kanghong Pharma	60
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Kanghong Pharma 2015-2016	61
Table HUAHAI Company Profile	61
Figure Depression Drugs Product Picture of HUAHAI	63
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of HUAHAI 2015-2016	63
Table Raw Material Suppliers Analysis and Picture	64
Table Key Suppliers of Raw Materials	65
Table Manufacturing Cost Structure of Depression Drugs	67
Figure USA Overview of Average Hourly Wages 2016-2017 (USD/Hour)	68
Figure USA Overview of Labor Costs 2013-2016 (110 Index Points)	68
Figure Cost of Employing a Factory Worker	70
Figure 2016 Estimated Labor Costs for the Whole Economy in Europe	71
Figure Monthly Minimum Wages in Asia 2016	72
Figure China Overview of Average Yearly Wages 2016-2017 (CNY/Year)	73
Figure Japan Overview of Average Monthly Wages 2016-2017 (JPY Thousand/Month)	73
Table Average Price of Electricity to Ultimate Customers	74
Figure Electricity Prices for Household Consumers in 2016	75
Figure Summary of the Driving Assumptions	76
Figure Industrial Electric Rates 2016 (PER KWH)	77
Figure Manufacturing Process Analysis of Depression Drugs	79
Figure Depression Drugs Industrial Chain Analysis	80
Table Major Buyers of Depression Drugs	81
Figure Setting Pricing Policy	85
Table Distributors/Traders List	88
Figure Global GDP Map 2016	93
Figure EU GDP Change 2006-2016	93
Figure German CPI Change 2016-2017	94
Figure UK CPI Change 2007-2016	94
Figure Japan GDP Change 2014-2017	95
Figure Japan CPI Change in 2016	95
Figure China GDP Change 2014-2017	95
Figure China CPI Change 2016-2017	96
Figure US GDP Change 2013-2016	96
Figure US CPI Change 2016-2017	97
Figure Global Depression Drugs Revenue (M USD) and Growth Rate (%) Forecast (2017-2022)	98
Table Global Depression Drugs Revenue Forecast by Regions (2017-2022)	98
Table Global Depression Drugs Sales Market Share (%) Forecast by Regions (2017-2022)	99
Figure Global Depression Drugs Sales Market Share (%) Forecast by Regions (2017-2022)	99
Figure Global Depression Drugs Sales Market Share (%) Forecast by Regions 2022	100
Figure North America Depression Drugs Revenue and Growth Rate (%) Forecast (2017-2022)	101
Figure Europe Depression Drugs Revenue and Growth Rate (%) Forecast (2017-2022)	102
Figure Asia-Pacific Depression Drugs Revenue and Growth Rate (%) Forecast (2017-2022)	103
Figure South America Depression Drugs Revenue and Growth Rate (%) Forecast (2017-2022)	104
Figure Middle East and Africa Depression Drugs Revenue and Growth Rate (%) Forecast (2017-2022)	105
Table Global Depression Drugs Revenue (M USD) Forecast by Type (2017-2022)	105
Table Global Depression Drugs Revenue Market Share (%) Forecast by Type (2017-2022)	105
Figure Global Depression Drugs Revenue Market Share (%) Forecast by Type (2017-2022)	106
Table Global Depression Drugs Revenue Forecast by Application (2017-2022)	106
Figure Global Depression Drugs Sales Forecast by Application (2017-2022)	107 



To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $2900
Multi User - US $5800
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify